Biblioteca Humberto Rosselli Quijano
Información del autor
Documentos disponibles escritos por este autor (1)
Refinar búsqueda
[artículo]
| Título : |
Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder |
| Tipo de documento: |
texto impreso |
| Autores: |
Marcio Versiani, Autor ; Mohammed Amin, Autor ; Guy Chouinard, Autor |
| Fecha de publicación: |
2023 |
| Artículo en la página: |
pp. 28-34 |
| Idioma : |
Inglés (eng) Idioma original : Inglés (eng) |
| Palabras clave: |
Antidepresivos, Trastorno depresivo mayor, Morfolinas. |
| Resumen: |
The efficacy and tolerability of reboxetine, a unique selective noradrenaline reuptake inhibitor, were compared with those of placebo in a 6-week, randomized, double-blind study of hospitalized patients with a DSM-III-R diagnosis of major depressive disorder. Fifty-two patients (25 in the placebo group, 27 in the reboxetine group) were included in the efficacy analysis. |
| Link: |
./index.php?lvl=notice_display&id=31228 |
in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 28-34
[artículo] Double-blind, placebo-controlled study with reboxetine in inpatients with severe major depressive disorder [texto impreso] / Marcio Versiani, Autor ; Mohammed Amin, Autor ; Guy Chouinard, Autor . - 2023 . - pp. 28-34. Idioma : Inglés ( eng) Idioma original : Inglés ( eng) in Journal of Clinical Psychopharmacology > Año 2000 - Vol. 20 - No. 1 (Febrero) . - pp. 28-34
| Palabras clave: |
Antidepresivos, Trastorno depresivo mayor, Morfolinas. |
| Resumen: |
The efficacy and tolerability of reboxetine, a unique selective noradrenaline reuptake inhibitor, were compared with those of placebo in a 6-week, randomized, double-blind study of hospitalized patients with a DSM-III-R diagnosis of major depressive disorder. Fifty-two patients (25 in the placebo group, 27 in the reboxetine group) were included in the efficacy analysis. |
| Link: |
./index.php?lvl=notice_display&id=31228 |
|
